Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study
The combination of formoterol fumarate and fluticasone propionate significantly improved lung function, asthma control, and quality of life, demonstrating marked effectiveness and safety with both DPI and MDI in Indian asthma patients.
Authors
- Rajesh Venkitakrishnan
- Kamlesh B. Patel (ORCID: https://orcid.org/0000-0001-7441-2102)
- Manish Kumar Jain (ORCID: https://orcid.org/0000-0001-9898-0382)
- Srimonti Dutta (ORCID: https://orcid.org/0000-0003-2666-4713)
- Shital Patil (ORCID: https://orcid.org/0000-0003-0502-5904)
- Sarat Kumar Behera
- Ronak Panwala
- Rahul K Jalan
- Kundan Nivangune
Institutions
- Lupin Pharmaceuticals (India) (IN)
- Maharaja Engineering College (IN)
- Chest Diseases Hospital (KW)
- Rajagiri Hospital (IN)
- Pulmonary and Allergy Associates (US)
- Institute of Medical Sciences and Sum Hospital (IN)
- Apollo Hospitals (IN)
Publication Details
- Journal
- Journal of the Association of Physicians of India
- Published
- 2025-11-10
- DOI
- https://doi.org/10.59556/japi.73.1251
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00